Intuitive Surgical, Inc. vs Shell PLC — how do they compare? Intuitive Surgical, Inc. trades at $424 (market cap $146.76B), while Shell PLC trades at $100.36 (market cap $284.34B). The key difference: Shell PLC is the larger of the two by market cap, and Shell PLC pays a 3.12% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Shell PLC for 90 Days on average.
| ISRG | SHEL | |
|---|---|---|
Market Cap | $146.76B | $284.34B |
Volume | 2,529,814 | 9,097,469 |
Sector | Health | Energy |
52-Week High | $592.85 | $100.20 |
52-Week Low | $332.02 | $70.31 |
Typical Hold Time | 84 Days | 90 Days |
Enterprise Value | $141.54B | $326.04B |
Dividend Yield | — | 3.12% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $423.96, up 2.28% with strong bullish momentum. The stock shows robust fundamentals with 2025 revenue reaching $10.06B and net income of $2.86B, maintaining 28.45% net margins. Recent quarters consistently beat EPS estimates, while technical indicators signal bullish moving averages. Analyst consensus remains strongly positive with 70% buy ratings and $480.78 price target, representing 13% upside potential.
ISRG's leadership in robotic surgery and expanding international presence in India and Japan provide growth catalysts, though China weakness and competitive pressures present risks. The stock's premium valuation (P/E 47.64) reflects high growth expectations, requiring continued execution. Current levels near resistance at $427 may test near-term momentum ahead of Q3 earnings.
Shell (SHEL) trades at $100.18, up 3.44% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with a P/E of 11.08, ROE of 14.35%, and recent earnings beats. Recent developments include the LNG Canada Phase 2 expansion approval, doubling export capacity, positioning Shell for long-term LNG growth. Cash flow remains healthy despite a temporary net outflow in 2025.
Shell presents a compelling investment case with attractive valuation, strong profitability, and strategic LNG expansion. Risks include revenue volatility from oil prices and execution challenges in major projects. Analyst consensus is bullish with a $102.53 price target, suggesting modest upside from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →